Sumitra Thongprasert
Chiang Mai, 50000, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Afatinib in locally advanced/metastatic NSCLC harboring common EGFR mutations, after chemotherapy: a Phase IV study.
Journal: Lung cancer management
Published: December 07, 2019
Cancer medicines in Asia and Asia-Pacific: What is available, and is it effective enough?
Journal: ESMO open
Published: December 17, 2018
Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand.
Journal: Value in health regional issues
Published: September 06, 2018
Biomarker Testing for Personalized Therapy in Lung Cancer in Low- and Middle-Income Countries.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: June 01, 2017
Crizotinib treatment for advanced non-small-cell lung cancer patients: a budget impact analysis based in Thailand.
Journal: Current medical research and opinion
Published: March 10, 2017
ESMO Women for Oncology 2016: a very personal tale of my professional life in Asia.
Journal: ESMO open
Published: December 13, 2016
Efficacy according to blind independent central review: Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin/paclitaxel in Asian patients with EGFR mutation-positive advanced NSCLC.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 31, 2016
Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study.
Journal: Cancer research and treatment
Published: September 02, 2016
Pathway Targeted Immunotherapy: Rationale and Evidence of Durable Clinical Responses with a Novel, EGF-directed Agent for Advanced NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 13, 2016
Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival.
Journal: Journal of the National Cancer Institute
Published: April 30, 2016
The prevalence of expression of MAGE-A3 and PRAME tumor antigens in East and South East Asian non-small cell lung cancer patients.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 28, 2016
Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 30, 2015
Last Updated: 09/26/2026